EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC-ND 4.0

Nanoparticle pharmacomicrobiomics: Reprogramming the microbiome–immune axis for cancer immunotherapy

Kazi Sabnam Siddiqua, Shahabab Ahmad Farooqui, Yongmin Zhang, Lu Wang, Gen Zhang, Fuquan Jiang, Ting-Chi Wen

Pharmacological Research · 2026-11 · 233 · 108481

DOI: 10.1016/j.phrs.2026.108481 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Pharmacological Research, 2026-11. Verfasst von Kazi Sabnam Siddiqua und 6 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Green Pesticide, Key Laboratory of Green Pesticide and Agricultural Bioengineering, Ministry of Education, Guizhou University…. Hauptthemen laut MEDLINE: Immunotherapy, Neoplasms, Nanoparticles, Gastrointestinal Microbiome. Die Arbeit nennt 250 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ImmunotherapyNeoplasmsNanoparticlesGastrointestinal MicrobiomeHumansAnimals

Stichwörter der Autor:innen

Cancer immunotherapyGut microbiomeGut-Tumor AxisImmune modulationNanomedicineNanoparticlesPharmacomicrobiomics

Autor:innen und Institutionen

  • State Key Laboratory of Green Pesticide, Key Laboratory of Green Pesticide and Agricultural Bioengineering, Ministry of Education, Guizhou University, Guiyang, Guizhou, 550025, China; Engineering Research Center of Sout…
  • Sorbonne Université, CNRS, Institut Parisien de Chimie Moléculaire, UMR 8232, 4 Place Jussieu, Paris, 75005, France.
  • Department of Cell Biology, School of Basic Medicine, Nanjing Medical University, Nanjing, 211166, China.
  • Fujian Provincial Key Laboratory of Innovative Drug Target Research, School of Pharmaceutical Sciences, Xiamen University, Xiamen, China.

Zitieren

APA

Siddiqua, K. S., Farooqui, S. A., Zhang, Y., Wang, L., Zhang, G., Jiang, F., & Wen, T. C. (2026). Nanoparticle pharmacomicrobiomics: Reprogramming the microbiome–immune axis for cancer immunotherapy. Pharmacological Research, 233, 108481. https://doi.org/10.1016/j.phrs.2026.108481

Vancouver

Siddiqua KS, Farooqui SA, Zhang Y, Wang L, Zhang G, Jiang F, et al. Nanoparticle pharmacomicrobiomics: Reprogramming the microbiome–immune axis for cancer immunotherapy. Pharmacological Research. 2026;233:108481. doi:10.1016/j.phrs.2026.108481

BibTeX
@article{Siddiqua2026,
  author = {Siddiqua, Kazi Sabnam and Farooqui, Shahabab Ahmad and Zhang, Yongmin and Wang, Lu and Zhang, Gen and Jiang, Fuquan and Wen, Ting-Chi},
  title = {Nanoparticle pharmacomicrobiomics: Reprogramming the microbiome–immune axis for cancer immunotherapy},
  journal = {Pharmacological Research},
  year = {2026},
  volume = {233},
  pages = {108481},
  doi = {10.1016/j.phrs.2026.108481}
}
Kostenlos starten →